Sangamo Therapeutics
SGMO
$0.51
Share price
5.44%
Change (1 day)
-68.43%
Change (1 year)
Sangamo Therapeutics (SGMO) Fails to deliver data
Key failure to deliver metrics for Sangamo Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.02 M
- Last 3 months FTD volume: $0.14 M
- Last year FTD volume: $1.62 M
Failures to deliver for Sangamo Therapeutics (SGMO) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Sangamo Therapeutics (SGMO) - since 2013
Volume in USD (price x number of shares), data since 2013Sangamo Therapeutics (SGMO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.14 M | -97.08% |
| 2023 | $4.91 M | -20.95% |
| 2022 | $6.21 M | -48.43% |
| 2021 | $12.05 M | 13.65% |
| 2020 | $10.6 M | -37.79% |
| 2019 | $17.04 M | -14.89% |
| 2018 | $20.03 M | 137.05% |
| 2017 | $8.45 M | 53.48% |
| 2016 | $5.5 M | -84.06% |
| 2015 | $34.54 M | 110.75% |
| 2014 | $16.39 M | 339.07% |
| 2013 | $3.73 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $0.14 B | $0.60 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Biogen BIIB | $17.8 M | $72.14 M | 🇺🇸 USA |
 Dow DOW | $10.74 M | $58.09 M | 🇺🇸 USA |
 Gilead Sciences GILD | $49.76 M | $0.27 B | 🇺🇸 USA |
 Merck MRK | $8.48 M | $0.18 B | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $15.22 M | $43.68 M | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $2.19 M | $7.77 M | 🇺🇸 USA |